Taking a Different Approach to Pancreatic Cancer Treatment
When Dr. Steve Bigelsen was diagnosed with stage IV pancreatic cancer, chemosensitivity testing led him to treatments beyond standard of care.
When Dr. Steve Bigelsen was diagnosed with stage IV pancreatic cancer, chemosensitivity testing led him to treatments beyond standard of care.
Samuel Chi describes his search for a pancreatic cancer treatment that allows him to live comfortably and reduce his tumor so he can have surgery.
Researchers are looking at adding checkpoint drugs–a type of immunotherapy–to standard chemoradiation to shrink pancreatic cancer for surgery.
Irwin Hausman lives a relatively comfortable life with pancreatic cancer, thanks to a clinical trial using low-dose chemotherapy and high-dose vitamin C.
Richard Valdes has alternated standard pancreatic cancer treatments with clinical trials of immunotherapy and a pancreatic vaccine during his treatment.
A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.
A chemoradiation clinical trial tests standard chemotherapy plus an anti-malaria drug and compares two types of radiation treatments, to slow tumor growth.
A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.